Value-based care doesn’t have to end independent practices

The transition to value-based care has led to consolidation and increased physician employment, but smaller practices may find different options in pursuing alignments with other organizations that don’t involve giving up their independent status.

Pressures on independent practices have led to physician ownership dropping below 50 percent for the first time, according to a 2017 American Medical Association survey. Regulators have also recognized the problem as well, with CMS proposing to exempt hundreds of thousands more clinicians from the new Merit-based Incentive Payment System (MIPS) in 2018. Scott Disch, MPH, vice president of performance management and operations at Privia Health, said it’s not just an issue of perception driving this trend.

“It’s a real problem for them,” he said to HealthExec. “It’s different managing—what I call ‘in your practice’ versus ‘on your practice.’ It’s a whole different component, skill set and technology.”

Disch’s presentation at June’s Healthcare Financial Management Association (HFMA) conference in Orlando focused on Privia’s experience as a physician practice management company, which he said has grown to around 1,600 providers in six states, 80 percent of them being in primary care. By aligning with a larger organization involving different primary care providers and specialists—whether it be as a virtual group, accountable care organization or a larger practice—physicians, he said, can choose to remain independent without sacrificing profitability or avoiding population health.

That choice comes with several hurdles, Disch admitted. Some are financial, like finding a partner with some capital, and others are operational, such as aligning with the right post-acute care provider and making sense of all the patient data across different practices.

“I really find across the country they struggle with not only understanding how to get the data to take action, but how do they set up the workflows to take the proper action each time,” he said.

Repeatedly in his interview with HealthExec Disch emphasized there’s no single correct model for independent practices to follow.

“I think it’s figuring out, for independent physicians, what’s the right angle to take,” Disch said.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.